Exhibit 10.58

 

FORM OF LIEN RELEASE AUTHORIZATION LETTER

 

September 12, 2003

 

Antares Pharma, Inc.

707 Eagleview Boulevard

Exton, PA 19341

 

Pursuant to that certain Amended and Restated Security Agreement, dated as of
January 31, 2003, by and among Xmark Fund, L.P., Xmark Fund, Ltd., SDS Merchant
Fund, L.P. (collectively, the “Investors”) and Antares Pharma, Inc. (“the
Company”), the Company granted to the Investors a security interest in certain
of the assets of the Company. In connection with that certain Securities
Exchange Agreement, dated as of September 12, 2004, by and among the Investors
and the Company, this letter will confirm that you are authorized to file a
UCC-3 terminating the aforesaid security interest.

 

Very truly yours,

 

By:

 

--------------------------------------------------------------------------------

   

Name:

Title: